Cargando…
Successful Treatment and Five Years of Disease-free Survival in a Donor Transmitted Metastatic Melanoma with Ipilimumab Therapy
Approximately 7% of deceased donors have unknown cancer at the time of organ procurement. More than half of these have no apparent contraindication to organ donation. The commonest transmitted malignancy is renal cell cancer (19%), followed by melanoma (17%). Donor transmission of melanoma has been...
Autores principales: | Singh, Priyamvada, Pandey, Deepali, Rovin, Brad, Pesavento, Todd E, Olencki, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634286/ https://www.ncbi.nlm.nih.gov/pubmed/31328051 http://dx.doi.org/10.7759/cureus.4658 |
Ejemplares similares
-
Which Is a Better Predictor of GFR Decline: 24-h Urine Protein or 24-h Protein–Creatinine Ratio? An Exploration of the MDRD Study Data
por: Ayoub, Isabelle, et al.
Publicado: (2022) -
Metastatic melanoma patients’ sensitivity to ipilimumab cannot be predicted by tumor characteristics
por: Rossfeld, Kara, et al.
Publicado: (2017) -
Successful Live Kidney Transplantation After Chikungunya Disease in the Donor
por: Moura-Neto, José Andrade, et al.
Publicado: (2017) -
Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
por: Hui, Jessica W., et al.
Publicado: (2020) -
Frailty in Patients With Chronic Kidney Disease Stage Five
por: Joseph, Jerry, et al.
Publicado: (2023)